Research Summaries

Research Summary
Research Summary
07/28/2025
Anthony Calabro, MA
The results from a single-center study show that adopting institutional guidelines favoring oral antibiotics can safely reduce reliance on intravenous therapy, streamline care, and maintain clinical...
07/28/2025
ACFAS Conference Coverage
ACFAS Conference Coverage
05/22/2025
Kate Young
A new retrospective study presented at the American College of Foot and Ankle Surgeons 2025 Scientific Conference suggests a potential link between long-term warfarin use and higher rates of ankle fracture...
05/22/2025
ACFAS Conference Coverage
ACFAS Conference Coverage
03/27/2025
Miranda Manier, BA
A retrospective analysis comparing fixation techniques for intra-articular calcaneal fractures found that screw-only fixation was associated with faster return to activity and showed similar union rates and...
03/27/2025
Research Summary
Research Summary
10/16/2024
Miranda Manier, BA
A recent study found that carrimycin significantly improved immune function and reduced disease severity in patients with tumors who have sepsis, highlighting its potential as an effective immune-modulating...
10/16/2024
Research Summary
Research Summary
07/02/2024
Researchers who are a part of the American Gastroenterological Association (AGA) developed a list of guidelines for the use of fecal microbiota-based therapies in patients with Clostridioides difficile...
07/02/2024
Research Summary
Research Summary
04/05/2024

Anthony Calabro, MA

Anthony Calabro, MA
An international task force of 35 pediatric experts developed and validated new criteria for sepsis and septic shock in children and adolescents based on a large international database and a systematic...
04/05/2024
FDA Alert
FDA Alert
06/01/2023
Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
Research Summary
Research Summary
02/24/2023
Researchers sought to determine whether adults hospitalized for sepsis are at an increased risk of death or rehospitalization for cardiovascular events.
02/24/2023
Disease Prevention
Disease Prevention
12/13/2022
Following three studies that examined its safety and efficacy, the FDA approves the first fecal microbiota product to prevent recurring Clostridioides difficle infection in patients.
12/13/2022
Medication
Medication
10/26/2022
A new drug combination was found to be more effective for treating UTIs and acute pyelonephritis compared to the current standard treatment approach.
10/26/2022